Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release May 09 2022

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE · · 3 pages · English

On 6ix: 6ix.com/news/press-release-may-09-2022-6

Watch Glenmark Pharmaceuticals' latest callGlenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call · Replay · Nov 6

Release

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 09-May-2022 titled Glenmark Pharmaceuticals receives tentative ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005% 0.064%

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases